Annual Current Assets
$289.71 M
+$46.71 M+19.22%
December 31, 2023
Summary
- As of February 8, 2025, VRNA annual total current assets is $289.71 million, with the most recent change of +$46.71 million (+19.22%) on December 31, 2023.
- During the last 3 years, VRNA annual current assets has risen by +$87.20 million (+43.06%).
- VRNA annual current assets is now at all-time high.
Performance
VRNA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$364.25 M
-$52.04 M-12.50%
September 30, 2024
Summary
- As of February 8, 2025, VRNA quarterly total current assets is $364.25 million, with the most recent change of -$52.04 million (-12.50%) on September 30, 2024.
- Over the past year, VRNA quarterly current assets has dropped by -$52.04 million (-12.50%).
- VRNA quarterly current assets is now -12.50% below its all-time high of $416.29 million, reached on June 30, 2024.
Performance
VRNA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
VRNA Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.2% | -12.5% |
| 3 y3 years | +43.1% | +97.4% |
| 5 y5 years | +218.6% | +484.2% |
VRNA Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.3% | -12.5% | +162.8% |
| 5 y | 5-year | at high | +433.6% | -12.5% | +1071.0% |
| alltime | all time | at high | >+9999.0% | -12.5% | >+9999.0% |
Verona Pharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $364.25 M(-12.5%) |
| Jun 2024 | - | $416.29 M(+53.1%) |
| Mar 2024 | - | $271.84 M(-6.2%) |
| Dec 2023 | $18.42 M(+11.8%) | $289.71 M(+4.8%) |
| Sep 2023 | - | $276.53 M(-3.9%) |
| Jun 2023 | - | $287.83 M(-6.2%) |
| Mar 2023 | - | $306.89 M(+26.3%) |
| Dec 2022 | $16.47 M(-0.3%) | $243.00 M(-6.0%) |
| Sep 2022 | - | $258.45 M(+86.4%) |
| Jun 2022 | - | $138.63 M(-9.4%) |
| Mar 2022 | - | $152.96 M(-10.1%) |
| Dec 2021 | $16.52 M(+870.9%) | $170.06 M(-7.8%) |
| Sep 2021 | - | $184.49 M(-14.7%) |
| Jun 2021 | - | $216.28 M(+14.7%) |
| Mar 2021 | - | $188.60 M(-6.9%) |
| Dec 2020 | $1.70 M(-12.1%) | $202.50 M(-4.7%) |
| Sep 2020 | - | $212.47 M(+583.1%) |
| Jun 2020 | - | $31.11 M(-19.9%) |
| Mar 2020 | - | $38.84 M(-28.5%) |
| Dec 2019 | $1.94 M(-50.5%) | $54.30 M(-12.9%) |
| Sep 2019 | - | $62.35 M(-15.0%) |
| Jun 2019 | - | $73.33 M(-9.8%) |
| Mar 2019 | - | $81.28 M(-10.6%) |
| Dec 2018 | $3.91 M(+19.2%) | $90.94 M(-5.8%) |
| Sep 2018 | - | $96.52 M(-5.5%) |
| Jun 2018 | - | $102.10 M(-9.4%) |
| Mar 2018 | - | $112.70 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $3.28 M(+13.9%) | $117.68 M(-5.0%) |
| Sep 2017 | - | $123.84 M(-4.6%) |
| Jun 2017 | - | $129.86 M(+140.2%) |
| Dec 2016 | $2.88 M(-14.4%) | $54.05 M(+1041.1%) |
| Jun 2016 | - | $4.74 M(-42.6%) |
| Dec 2015 | $3.36 M(+15.3%) | $8.26 M(-34.2%) |
| Jun 2015 | - | $12.54 M(-28.4%) |
| Dec 2014 | $2.91 M(+3.7%) | $17.52 M(-17.2%) |
| Jun 2014 | - | $21.16 M(+1403.6%) |
| Dec 2013 | $2.81 M(+6.4%) | $1.41 M(-18.7%) |
| Jun 2013 | - | $1.73 M(-8.4%) |
| Dec 2012 | $2.64 M(+7.0%) | $1.89 M(-52.8%) |
| Jun 2012 | - | $4.00 M(-1.5%) |
| Dec 2011 | $2.47 M(+0.9%) | $4.06 M(+87.0%) |
| Jun 2011 | - | $2.17 M(-32.0%) |
| Dec 2010 | $2.45 M(-2.9%) | $3.20 M(-28.8%) |
| Jun 2010 | - | $4.49 M(-13.5%) |
| Dec 2009 | $2.52 M(+10.6%) | $5.19 M(+81.5%) |
| Jun 2009 | - | $2.86 M(-22.6%) |
| Dec 2008 | $2.28 M(-26.0%) | $3.69 M(-43.0%) |
| Jun 2008 | - | $6.49 M(+119.1%) |
| Dec 2007 | $3.08 M(+1.5%) | $2.96 M(-24.8%) |
| Jun 2007 | - | $3.94 M(-16.8%) |
| Dec 2006 | $3.03 M(>+9900.0%) | $4.73 M(+149.4%) |
| Jun 2006 | - | $1.90 M(+11.3%) |
| Dec 2005 | $0.00 | $1.71 M(-5.1%) |
| Jun 2005 | - | $1.80 M |
FAQ
- What is Verona Pharma annual total current assets?
- What is the all time high annual current assets for Verona Pharma?
- What is Verona Pharma annual current assets year-on-year change?
- What is Verona Pharma quarterly total current assets?
- What is the all time high quarterly current assets for Verona Pharma?
- What is Verona Pharma quarterly current assets year-on-year change?
What is Verona Pharma annual total current assets?
The current annual current assets of VRNA is $289.71 M
What is the all time high annual current assets for Verona Pharma?
Verona Pharma all-time high annual total current assets is $289.71 M
What is Verona Pharma annual current assets year-on-year change?
Over the past year, VRNA annual total current assets has changed by +$46.71 M (+19.22%)
What is Verona Pharma quarterly total current assets?
The current quarterly current assets of VRNA is $364.25 M
What is the all time high quarterly current assets for Verona Pharma?
Verona Pharma all-time high quarterly total current assets is $416.29 M
What is Verona Pharma quarterly current assets year-on-year change?
Over the past year, VRNA quarterly total current assets has changed by -$52.04 M (-12.50%)